MARCUS CORP

MCS
About the company

The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. The company operates a family entertainment center and multiscreen motion picture theatres under the Marcus Theatres, Movie Tavern by Marcus, and BistroPlex brand names.

Country: United StatesPrice: $26.95Market Cap: $837.9M

Investment snapshot

12%positive consensus
Scored 1d ago

Positive

2

BUY / PASS

Neutral / negative

2 / 12

NEUTRAL / FAIL

Median fair value

$5.45

-79.8% vs price

Models with upside

0 / 17

Positive margin of safety

Strongest signal

6 of 10 pass — Dreman, Pabrai, Ackman +1 more object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedPASSFAILPASSFAILFAILFAILFAILFAILFAILNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A-310.8%N/A-377.0%N/AN/A-4546.6%-413.3%-70.6%N/A-5634.0%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-27

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-27

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Qualitative assessment

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-27

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Where It Passes

  • Cash Flow60% pass✓ 7✗ 5▾

    6 of 10 pass — Dreman, Pabrai, Ackman +1 more object

    Free Cash Flow Proxy$12.7M
    ✓BuffettPositive and growing
    FCF Positive and Growing$76.9M
    ✓LynchPositive and growing
    Operating Cash Flow$84.2M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=8.30%, ROA=1.25%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=0.1%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive13/21 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap
    ✗Ackman>= 4%
    Price / FCF per Share
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency20/21 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$76.9M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+9.18%; #846/4519 (top 18.7%)
    ✗OshaughnessyTop 10% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 6✗ 29▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)13/32 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)27/32 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-1.6%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)2.2% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$12.7M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE5.2%
    ✗Lynch> 15%
    EBIT / Enterprise Value4.3%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=4.3%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets1.25%
    ✓PiotroskiROA > 0
    ROA Change YoY-0.75% -> 1.25% (delta: +2.00%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=8.30%, ROA=1.25%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue3.4%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity5.2%
    ✗Dreman> 12%
    Margin of Safety
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity1.4% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency27/31 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue4.9%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity5.2%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend4.7% (2023) -> 2.2% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 4.7% -> 2.2%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+3.01%; #2372/6340 (top 37.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+5.25%; #2429/5226 (top 46.5%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0184; #1348/5884 (top 22.9%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✗ 28▾

    All 13 investors flag MCS's valuation

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value4.3%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=4.3%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)
    ✗Dreman< 8x
    Price / Book Value per Share
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation Reasonableness
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=0.1%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share
    ✗Ackman<= 25
    Price vs. Trailing Low187% of trailing low ($14.40)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+3.01%; #2372/6340 (top 37.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.5733; #2600/6449 (top 40.3%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.9755; #1790/5247 (top 34.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+9.18%; #846/4519 (top 18.7%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+41.62%; #783/6202 (top 12.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Efficiency0% pass✓ 1✗ 10▾

    No clean pass — all 8 investors flag at least one efficiency criterion

    Current Ratio0.67
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)1.0%
    ✗Buffett> 10%
    ROIC - WACC-9.0%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.52 -> 0.40
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.70x -> 0.75x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities0.67
    ✗Dreman> 1.5
    Return on Invested Capital5.0%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=4.2%; FY2024: ROIC=2.0%; FY2025: ROIC=2.2%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC3.0% (RR=60% x ROIC=5.0%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 2.2%)
    ✗SleepROIC > 12% in a majority of years
  • Valuation models0% pass✗ 6▾

    MCS overvalued: all 6 models price fair value below $26.95 (median $5.45)

    Buffett fair value$6.56
    ✗Buffett-310.8% margin vs $26.95
    Greenblatt fair value$5.65
    ✗Greenblatt-377.0% margin vs $26.95
    Munger fair value$0.58
    ✗Munger-4546.6% margin vs $26.95
    Pabrai fair value$5.25
    ✗Pabrai-413.3% margin vs $26.95
    Akre fair value$15.80
    ✗Akre-70.6% margin vs $26.95
    Ackman fair value$0.47
    ✗Ackman-5634.0% margin vs $26.95
  • Growth13% pass✓ 3✗ 10▾

    7 of 8 flag MCS's growth — Graham, Lynch, Dreman +4 more

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: 0.8% vs Rev: 3.1%
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency27/31 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth3.1%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 4.7% -> 2.2%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR26.1%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts14% pass✓ 2✗ 12▾

    Split decision: 12 FAIL · 2 PASS · 2 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (1/9)✗LynchFAIL (3/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 5)✗DremanFAIL (1/11)✓MungerPASS (2/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (3/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)✗SleepFAIL (2/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Debt & Leverage33% pass✓ 7✗ 8▾

    8 of 12 flag MCS's debt & leverage — Graham, Buffett, Lynch +5 more

    Debt Levels0.32
    ✓MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    LT Debt vs Net Current AssetsLT Debt $149.2M vs NCA $-51.9M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.32, IC: 3.7x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.32
    ✓Lynch< 0.33
    Cash - Long-term Debt$-88.9M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change14.27% -> 15.67%
    ✗PiotroskiDecreased YoY
    Current Assets / Current Liabilities0.67
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0.32
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Interest Coverage & Debt/EBITDAIC=3.7x, D/EBITDA=1.4x
    ✓MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.32
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.3157; #2040/4210 (top 48.5%)
    ✗AsnessTop 30% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Entertainment
SIC Sector: Motion Pictures
Size: Small Cap($837.9M)
Revenue: $758.5M+3.1% YoY
Net Income: $12.7M+263.0% YoY

Financial Snapshot

Operating Margin2.2%
Return on Equity2.8%
Debt / Equity0.35
Current Ratio0.40
Buybacks (1y)$18.8M
Buybacks (2y)$29.1M

Similar Companies

DISWalt Disney Co
$205.4B
MSGSMadison Square Garden Sports Corp.
$9.3B
CHDNChurchill Downs Inc
$6.8B
MTNVAIL RESORTS INC
$5.5B

Shareholder Return

Fiscal 2025

Share retirement not available for this company.

Buybacks
$18.8M
Dividends
$9.2M

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, dividends paid.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-27
FY 2024
Sources
  • 10-K · 2025-02-28
FY 2023
Sources
  • 10-K · 2024-03-01
FY 2022
Sources
  • 10-K · 2023-03-02
FY 2021
Sources
  • 10-K · 2022-03-03
Market Cap$837.9Mcurrent----------------
Revenue$817.4M↑9%$237.8M↑13%$231.7M↑12%$154.4M↑4%$758.5M↑3%$735.6M↑1%$729.6M↑8%$677.4M↑48%$458.2M
Operating Income$39.8M↑203%$30.3M↑33%$27.1M↑108%-$19.3M↑6%$17.1M↑6%$16.2M↓52%$33.9M↑308%$8.3M↑120%-$41.5M
Net Income$25.2M↑226%$18.8M↑16%$15.8M↑116%-$15.4M↑9%$12.7M↑263%-$7.8M↓153%$14.8M↑224%-$12.0M↑72%-$43.3M
EPS (Diluted)------------------
Gross Margin—————————
Operating Margin4.9%↑179%12.7%↑18%11.7%↑85%-12.5%↑9%2.2%↑2%2.2%↓53%4.7%↑279%1.2%↑114%-9.0%
ROE5.2%↑209%———2.8%↑266%-1.7%↓153%3.1%↑220%-2.6%↑72%-9.5%
Total Debt$151.7M↓6%$151.7M↓6%$151.6M↓16%$176.7M↓11%$159.0M$159.1M↓6%$169.9M↓6%$180.4M↓16%$215.1M
Shareholders' Equity$480.4M↑6%$480.4M↑6%$456.9M↑2%$441.2M$457.4M↓2%$464.9M↓1%$471.2M↑3%$456.1M↑1%$453.6M
Current Ratio0.67↑90%0.67↑90%0.44↑12%0.35↓17%0.40↓24%0.52↓16%0.62↑51%0.41↓13%0.47
Debt / Equity0.32↓11%0.32↓11%0.33↓17%0.40↓11%0.35↑2%0.34↓5%0.36↓9%0.40↓17%0.47
Operating Cash Flow$126.0M↑43%$38.4M↓2%$54.0M↑71%-$15.2M↑57%$84.2M↓19%$103.9M↑1%$102.6M↑10%$93.2M↑102%$46.3M
Free Cash Flow$76.9M↑4381%$28.4M↑56%$44.0M↑198%-$21.9M↑63%$989.0K↓96%$24.7M↓61%$63.9M↑13%$56.4M↑93%$29.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Entertainment

MCS vs Peers — Financial Grading

Revenue$758.5MBottom 25%
Net Income$12.7MMedian
ROE2.8%Median
D/E0.35Top 25%
Op. Margin2.2%Median
Curr. Ratio0.40Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Walt Disney CoDIS$205.4B$118.97$94.4B$12.4B11.3%0.3818.6%0.711/92/94/71/3F-Score 74/11
Madison Square Garden Sports Corp.MSGS$9.3B$314.46$1.0B$22.4M8.0%-1.031.4%0.451/93/91/70/3F-Score 51/11
Churchill Downs IncCHDN$6.8B$99.72$2.9B$383.0M37.9%5.0823.4%0.601/93/92/71/3F-Score 63/11
VAIL RESORTS INCMTN$5.5B$152.61$3.0B$280.0M66.0%7.3518.9%0.631/95/93/70/3F-Score 73/11
Cinemark Holdings, Inc.CNK$4.7B$40.80$3.1B$138.2M————1/90/92/70/3F-Score 11/11
Manchester United plcMANU$3.9B$22.43$914.4M$45.3M-17.0%3.29-2.8%0.381/90/90/70/3F-Score 51/11
Atlanta Braves Holdings, Inc.BATRA$3.7B$56.66$732.5M$23.4M-4.4%1.40-1.8%0.421/91/91/70/3F-Score 51/11
Brightstar Lottery PLCBRSL$1.8B$9.81$2.5B$147.0M16.8%4.77—0.763/92/91/71/3F-Score 44/11